Clinical Trials Logo

Apnea clinical trials

View clinical trials related to Apnea.

Filter by:

NCT ID: NCT00614250 Completed - Clinical trials for Sleep Apnea, Obstructive

Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the activity of 4 escalating doses of AVE0657 in comparison to placebo in patients with Obstructive Sleep Apnea Hypopnea Syndrome.

NCT ID: NCT00607893 Completed - Clinical trials for Cardiovascular Diseases

Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea

SASS
Start date: September 2006
Phase: N/A
Study type: Interventional

Sleep-disordered breathing (SDB) is a condition in which a person experiences frequent breathing pauses during sleep, also known as sleep apnea. There is evidence that the recurrent sleep arousal and associated shortage of oxygen in the body may increase risk for cardiovascular disease (CVD). It is believed that treatment with continuous positive airway pressure (CPAP) may reduce certain risk factors for heart disease, including markers of inflammation and oxidative stress. This study will evaluate the effectiveness of CPAP in reducing CVD risk factors in people with SDB.

NCT ID: NCT00607555 Completed - Infant, Premature Clinical Trials

A Study on the Effects of Feeding and Feeding Methods on Breathing Pattern in Very Low Birth Weight Preterm Infants

Start date: March 2008
Phase: N/A
Study type: Observational

In this study, we want to see how feeding affects breathing in small premature babies. Using a special feeding tube in the stomach, we can measure how the diaphragm (a large breathing muscle) might be affected by feeding. We also want to see if slowing down the feeding may lessen this effect.

NCT ID: NCT00603044 Completed - Clinical trials for Childhood Obstructive Sleep Apnea Syndrome (OSAS)

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in the adenoid tissues of children with OSAS. This will result in a local reduction in inflammation and edema explaining the improvement in OSAS.

NCT ID: NCT00591591 Completed - Clinical trials for Obstructive Sleep Apnea Syndrome

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

NIRS-OSAS
Start date: August 2007
Phase: Phase 3
Study type: Interventional

The goal of this trial is to assess the performance of the OxiplexTS—an absolute near-infrared oximeter—as an instrument to measure brain oxygenation and hemodynamics in sleep medicine as well as in the broader field of cardiovascular/cerebrovascular diagnostics.

NCT ID: NCT00575523 Completed - Arrhythmia Clinical Trials

Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy

atropinePEI
Start date: October 2003
Phase: Phase 4
Study type: Interventional

Ultrasound guided percutaneous ethanol injection (PEI) is an established method in the treatment of hepatocellular carcinoma (HCC) and considered a safe procedure with severe complications occurring rarely. Previous studies revealed, that the occurrence of bradycardia and sinuatrial blockage is quite frequent during ethanol instillation sometimes accompanied by clinical complications such as unconsciousness, respiratory arrest or seizure like symptoms. Study purpose is to evaluate whether the use of i.v. Atropine before starting ethanol instillation can prevent dysrhythmias during instillation. Study design: randomized, placebo controlled, double blinded study. Atropine or saline solution will be administered intravenously to 40 patients immediately before starting percutaneous ethanol instillation. A 6 line ECG with limb leads will be recorded at rest and during ethanol instillation to reveal possibly occurring dysrhythmias.

NCT ID: NCT00570115 Completed - Clinical trials for Sleep Apnea Syndromes

Left Atrial Volume and Function Evaluation in Patients With Obstructive Sleep Apnea

Start date: June 2007
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether patients with obstructive sleep apnea have any changes in left atrial morphology and function evaluated by echocardiography three dimensional

NCT ID: NCT00561860 Completed - Clinical trials for Obstructive Sleep Apnea-hypopnea

Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea

Start date: November 2007
Phase: N/A
Study type: Interventional

Although continuous positive airway pressure (CPAP) is an effective therapy for obstructive sleep apnea-hypopnea (OSAH), one of the major impediments to its use is poor compliance. Adherence with CPAP ranges from 50% to 75%, and subjective reports underestimate actual use. The primary objectives are to determine whether a remote monitoring system improves 3 month compliance (average hours of use/night), and reduces the costs of caring for patients with OSAH who are prescribed CPAP.

NCT ID: NCT00560586 Completed - Clinical trials for Obstructive Sleep Apnea

Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome

Start date: April 2004
Phase: Phase 4
Study type: Interventional

-Intranasal budesonide therapy may lead to improved symptoms and sleep study findings in children with mild obstructive sleep apnea with and without allergic rhinitis that would not be treated with T&A. The aim of the study is to conduct a randomized double blind cross-over trial comparing the effect of once a day intranasal budesonide therapy vs. placebo in children with mild sleep apnea that would not be candidates for T&A.

NCT ID: NCT00551499 Completed - Heart Failure Clinical Trials

Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF

Morpheus
Start date: June 2005
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to compare the Apnea- Hypopnea Index in HF patients with concomitant CSA, after 12 weeks of CRT alone to CRT in combination with one night of overdrive pacing. Secondary objectives are to evaluate the effects of a single night of overdrive pacing applied after 12 weeks of CRT vs. CRT alone on breathing events, sleeping events, and neurohormonal markers. An additional secondary objective of the study is to compare the efficacy of CRT in HF patients with concomitant CSA to HF patients without concomitant CSA.